Bhatt, Deepak L.

Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease: Insights From Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD)

Arnold, S. V., de Lemos, J. A., Rosenson, R. S., Ballantyne, C. M., Liu, Y., Mues, K. E., Alam, S., Elliott-Davey, M., Bhatt, D. L., Cannon, C. P., et al. (2019) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsClinical practice guidelines implementation

Cited by 130

Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study

Subherwal, S., Patel, M. R., Kober, L., Peterson, E. D., Bhatt, D. L., Gislason, G. H., Olsen, A.-M. S., Jones, W. S., Torp-Pedersen, C., & Fosbol, E. L. (2015) · European Journal of Preventive Cardiology

Peripheral Artery Disease ManagementHealthcare Systems and Public Health

Cited by 129

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke: Post Hoc Analysis From the LEADER Trial

Verma, S., Poulter, N. R., Bhatt, D. L., Bain, S. C., Buse, J. B., Leiter, L. A., Nauck, M. A., Pratley, R. E., Zinman, B., Ørsted, D. D., et al. (2018) · Circulation

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 127

The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

Bhatt, D. L., Bays, H. E., Miller, M., Cain, J. E., Wasilewska, K., Andrawis, N. S., Parli, T., Feng, S., Sterling, L., Tseng, L., et al. (2023) · Nature Medicine

Lipid metabolism and disordersFibroblast Growth Factor Research

Cited by 121

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: The randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

Mingrone, G., van Baar, A. C., Devière, J., Hopkins, D., Moura, E., Cercato, C., Rajagopalan, H., Lopez-Talavera, J. C., White, K., Bhambhani, V., et al. (2022) · Gut

Diabetes Treatment and ManagementBariatric Surgery and Outcomes

Cited by 120

The effect of dapagliflozin on albuminuria in DECLARE-TIMI 58

Mosenzon, O., Wiviott, S. D., Heerspink, H. J. L., Dwyer, J. P., Cahn, A., Goodrich, E. L., Rozenberg, A., Schechter, M., Yanuv, I., Murphy, S. A., et al. (2021) · Diabetes Care

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 113

The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study

Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Price, D. L., Chen, R., Udell, J., et al. (2011) · American Heart Journal

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 106

Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry

Suárez, C., Zeymer, U., Limbourg, T., Baumgartner, I., Cacoub, P., Poldermans, D., Röther, J., Bhatt, D. L., Steg, P. G., & REACH Registry Investigatorsa (2010) · Vascular Medicine

Peripheral Artery Disease ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 106

Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial

Verma, S., Bhatt, D. L., Bain, S. C., Buse, J. B., Mann, J. F. E., Marso, S. P., Nauck, M. A., Poulter, N. R., Pratley, R. E., Zinman, B., et al. (2018) · Circulation

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 105

Association of Severe Obstructive Sleep Apnea and Elevated Blood Pressure Despite Antihypertensive Medication Use

Walia, H. K., Li, H., Rueschman, M., Bhatt, D. L., Patel, S. R., Quan, S. F., Gottlieb, D. J., Punjabi, N. M., Redline, S., & Mehra, R. (2014) · Journal of Clinical Sleep Medicine

Obstructive Sleep Apnea ResearchBlood Pressure and Hypertension Studies

Cited by 104

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies

Olshansky, B., Chung, M. K., Budoff, M. J., Philip, S., Jiao, L., Doyle, Jr., Copland, C., Giaquinto, A., Juliano, R. A., & Bhatt, D. L. (2020) · European Heart Journal Supplements

Fatty Acid Research and HealthStatistical Methods in Clinical Trials

Cited by 103

Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke

Echouffo-Tcheugui, J. B., Xu, H., Matsouaka, R. A., Xian, Y., Schwamm, L. H., Smith, E. E., Bhatt, D. L., Hernandez, A. F., Heidenreich, P. A., & Fonarow, G. C. (2018) · European Heart Journal

Acute Ischemic Stroke ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 103

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles

Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Jiao, L., Tardif, J.-C., Gregson, J., Pocock, S. J., & Ballantyne, C. M. (2019) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 97

EPA and DHA containing phospholipids have contrasting effects on membrane structure

Sherratt, S. C. R., Juliano, R. A., Copland, C., Bhatt, D. L., Libby, P., & Mason, R. P. (2021) · Journal of Lipid Research

Fatty Acid Research and HealthLipid Membrane Structure and Behavior

Cited by 92

Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial

Leiter, L. A., Teoh, H., Braunwald, E., Mosenzon, O., Cahn, A., Kumar, K. M. P., Smahelova, A., Hirshberg, B., Stahre, C., Frederich, R., et al. (2015) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 87

Sex and Race/Ethnicity–Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults

Li, S., Fonarow, G. C., Mukamal, K. J., Liang, L., Schulte, P. J., Smith, E. E., DeVore, A., Hernandez, A. F., Peterson, E. D., & Bhatt, D. L. (2016) · Circulation: Cardiovascular Quality and Outcomes

Sex and Gender in HealthcareHealth disparities and outcomes

Cited by 85

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension – Insights From the SYMPLICITY HTN-3 Trial –

Kario, K., Bhatt, D. L., Kandzari, D. E., Brar, S., Flack, J. M., Gilbert, C., Oparil, S., Robbins, M., Townsend, R. R., & Bakris, G. (2016) · Circulation Journal

Blood Pressure and Hypertension StudiesObstructive Sleep Apnea Research

Cited by 84

Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

Krempf, M., Parhofer, K. G., Steg, P. G., Bhatt, D. L., Ohman, E. M., Röther, J., Goto, S., Pasquet, B., & Wilson, P. W. F. (2010) · The American Journal of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsAcute Ischemic Stroke Management

Cited by 82

Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization

Laskey, W. K., Alomari, I., Cox, M., Schulte, P. J., Zhao, X., Hernandez, A. F., Heidenreich, P. A., Eapen, Z. J., Yancy, C., Bhatt, D. L., et al. (2015) · Journal of the American Heart Association

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 80

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

Majithia, A., Bhatt, D. L., Friedman, A. N., Miller, M., Steg, P. G., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Juliano, R. A., Jiao, L., et al. (2021) · Circulation

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 74

Antithrombotic Therapy for Peripheral Artery Disease

Hussain, M. A., Al-Omran, M., Creager, M. A., Anand, S. S., Verma, S., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology

Peripheral Artery Disease ManagementAntiplatelet Therapy and Cardiovascular Diseases

Cited by 69

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Beckman, J. A., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., et al. (2022) · Journal of Diabetes and its Complications

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 64

Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease

Smolderen, K. G., Wang, K., de Pouvourville, G., Brüggenjürgen, B., Röther, J., Zeymer, U., Parhofer, K. G., Steg, P. G., Bhatt, D. L., & Magnuson, E. A. (2012) · European Journal of Vascular and Endovascular Surgery

Peripheral Artery Disease ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 61

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction

Gaba, P., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Juliano, R. A., Jiao, L., Doyle, R. T., et al. (2022) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 61